Aspercreme Lidocaine No-mess Plus Lavender Liquid
NDC Package 41167-0568-5
Package Information
Aspercreme Lidocaine No-mess Plus Lavender (lidocaine hcl) liquids is a medication used to prevent and relieve pain during certain medical procedures (such as inserting a tube into the urinary tract). This formulation utilizes a liquid delivery system. Marketed by Chattem, Inc., this product is identified by NDC 41167-0568 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 2197844 - lidocaine 4 % Topical Solution
- RxCUI: 2197844 - lidocaine 40 MG/ML Topical Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 41167 - Chattem, Inc.
- 41167-0568 - Aspercreme Lidocaine No-mess Plus Lavender
- 41167-0568-5 - 1 BOTTLE, WITH APPLICATOR in 1 CARTON / 73 mL in 1 BOTTLE, WITH APPLICATOR
- 41167-0568 - Aspercreme Lidocaine No-mess Plus Lavender
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (41167-0568). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 41167-0568-5 identifies a specific commercial package of 1 bottle, with applicator in 1 carton / 73 ml in 1 bottle, with applicator of Aspercreme Lidocaine No-mess Plus Lavender, a human over the counter drug labeled by Chattem, Inc.. This liquid is formulated for topical use and contains lidocaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chattem, Inc. on January 20, 2020. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to prevent and relieve pain during certain medical procedures (such as inserting a tube into the urinary tract). It is also used to numb the lining of the mouth, throat, or nose before certain medical procedures (such as intubation). Lidocaine jelly is also used to relieve pain caused by swelling of the urinary tract (urethritis). It works by numbing certain areas of the body that are moist. Lidocaine belongs to a class of drugs known as local anesthetics.
How is this Chattem, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 41167056805. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.